Skip to main content

AusPAR: Spikevax Bivalent Original/Omicron BA.4 - 5

Australian Public Assessment Report
Device/Product Name
Spikevax Bivalent Original/Omicron BA.4 - 5
Active ingredients
Elasomeran/davesomeran
AusPAR Date
Published
Submission Number
PM-2023-01714-1-2
Submission Type
Transition from provisional registration to full registration
Decision
Approved

Help us improve the Therapeutic Goods Administration site